[ Price : $8.95]
FDA grants CereVasc a breakthrough device designation for its investigational eShunt System and its use in treating communicating ...[ Price : $8.95]
FDA says its Electronic Submission Gateway Next Generation is live and ready to receive submissions.[ Price : $8.95]
Vanda Pharmaceuticals criticizes FDA for wrongly claiming that recent staff cuts and a new commissioner causes it to delay a compa...[ Price : $8.95]
Akeso says its ivonescimab met the primary endpoint in a pivotal Phase 3 trial for the first-line treatment of advanced squamous n...[ Price : $8.95]
The Association for Clinical Oncology tells the new leaders of FDA, NIH, and CMS it looks forward to working with them on behalf o...[ Price : $8.95]
Bristol Myers Squib says its Cobenfy showed positive results in the Phase 3 ARISE trial as an adjunctive therapy to atypical antip...[ Price : $8.95]
Former FDA associate commissioner Peter Pitts calls on the agency to revise drug labels with obesity safety and effectiveness info...[ Price : $8.95]
Lilly sues four additional drug compounders for illegally selling copies of its weight loss and diabetes drugs.